Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

93 Percent of Nucleoside-Naive Chronic Hepatitis B e-Antigen (HBeAg)-Negative Patients Achieved Undetectable Viral Load by Week 48 of Re-Treatment

PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company today announced data from a cohort of nucleoside-naive HBeAg-negative chronic hepatitis B patients (ETV-027/901, n=99). These data showed that patients who experienced recurrent levels of hepatitis B virus in the blood after interruption of treatment with BARACLUDE(R) (entecavir) achieved viral suppression and liver enzyme (ALT) normalization when re- treated for 48 weeks with BARACLUDE. The study results were presented at the 42nd Annual Meeting of the European Association for the Study of Liver Diseases (EASL) in Barcelona, Spain.

In this cohort, 93 percent of patients who were re-treated with BARACLUDE had undetectable viral load - the level of the hepatitis B virus in the blood - (HBV DNA <300 copies/mL, measured by a common assay - polymerase chain reaction or PCR) and 83 percent achieved liver enzyme normalization (ALT less than or equal to 1xULN) after 48 weeks of therapy.

"This study showed that when treated again with BARACLUDE for 48 weeks, patients achieved responses similar to those seen prior to treatment interruption, with safety results consistent with previously reported experience," said Hakan Senturk, MD, of the Ist.Univ.Cerrahpasa Tip Fak, Istanbul, Turkey.

No deaths or treatment discontinuations due to adverse events were reported in this cohort. The most common adverse events occurring in greater than 10 percent of patients were abdominal pain, fatigue, upper respiratory tract infection, nasopharyngitis, increased ALT, arthralgia, and headache.

About the Nucleoside-Naive HBeAg-Negative BARACLUDE(R) (entecavir) Re- Treatment Cohort

This analysis evaluated BARACLUDE(R) (entecavir) in nucleoside-naive chronic HBeAg-negative patie
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:11/26/2014)... , Nov. 26, 2014  Perrigo Company plc ("Perrigo") ... provider of "Quality Affordable Healthcare Products®," today announced the ... to the sale of 6,809,210 ordinary shares at a ... full exercise of the option to purchase up to ... LLC and Barclays Capital Inc., as representatives of the ...
(Date:11/26/2014)... 26, 2014 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... of previously announced concurrent financing transactions resulting in ... estimated offering expenses, Lexicon anticipates net proceeds of ... consisted of: , a public offering ... a registration statement that has been declared effective ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3New Pain Management Center Opens in Cumberland, Md. 2
... WASHINGTON, May 28 Leading international experts on ... ones and advocates to share the latest in ... Research Foundation,s,International Symposium on Malignant Mesothelioma, 2008, Thursday, ... Regency on Capitol Hill, in Washington,D.C., The ...
... Demonstrates Sustained and Significant Reductions in Cancer ... ... 28 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) announced today ... anticancer compound, ProLindac(TM) at the,International Symposium on Polymer Therapeutics: Laboratory ...
Cached Medicine Technology:International Symposium on Malignant Mesothelioma 2008 2Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium 2Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium 3
(Date:11/26/2014)... November 26, 2014 Healthpointe is proud ... Perris , and it will be led by ... in the field of Occupational Medicine and utilizes the ... Medicine specialist delivers quality care for employers and their ... health. , As an Occupational Medicine ...
(Date:11/26/2014)... Recently, Locks-Magnetic.com, a Chinese outstanding Maglocks supplier, is ... on the Internet. It also provides a big discount ... As a leading company in the electronic lock industry, ... buy high quality locks. It can meet the demands ... are not only useful but also affordable. However, inexpensive ...
(Date:11/26/2014)... iFitDress.com, a well-known wedding dress manufacturer and ... 16 cocktail dresses . Included in the new range ... all of these charming outfits are offered at deeply ... has promised that all of the sweet 16 cocktail ... worth mentioning that all of them are set according ...
(Date:11/26/2014)... November 26, 2014 Dr. Rod ... Distinguished Teaching Professor in the Department of Plastic ... facial fat compartments, fat grafting, and modern lift-and-fill ... an annual conference held by the American Society ... of this underlying facial structure were explored in ...
(Date:11/26/2014)... When you,re planning your holiday get-away, don,t forget ... -- such as skiing or hiking, a sports ... fail to take altitude into account when visiting ... of developing fatigue and other symptoms related to ... Melissa Tabor, an assistant professor of sports medicine ...
Breaking Medicine News(10 mins):Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3Health News:Fresh Products Launched by Famous Company Lock-Magnetic.com 2Health News:iFitDress.com: Trendy Sweet 16 Cocktail Dresses Unveiled 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Don't Let High Altitude Ruin Your Holiday Trip 2
... year in Jacksonville,nearly 600 adults experience some form ... to recovery lacked long-term support. Today, Brooks,Rehabilitation celebrated ... Florida created to help people with acquired brain ... The Brain Injury Association of America estimates that ...
... researcher, administrator, and,Chair Emeritus of the University of Louisville,s ... Foundation for,Biomedical Research (FBR) today announced its board of ... chairman of the board. Dr.,Polk succeeds the late Dr. ... years., "I am honored to represent the Foundation ...
... respiratory problems, CDC report says , , WEDNESDAY, Oct. 22 (HealthDay ... has soared 18 percent in the last decade, with an ... the condition, a new federal report says. , In 2007, ... reported to have had a food or digestive allergy in ...
... Oct. 22 Endocare, Inc.,(Nasdaq: ENDO ), an ... invasive technologies for tissue and tumor,ablation, today announced that ... Oppenheimer 19th Annual Healthcare Conference at 1:20,p.m. ET on ... at the,Waldorf Astoria hotel November 3-4 in New York ...
... supplier, DRE adds affordable, professionally refurbished ultrasound machines to its ... ... KY (PRWEB) October 22, 2008 -- DRE Inc. - named ... businesses in Louisville, Ky. — now sells professionally refurbished ...
... allows more efficient use of larger cleanrooms. , ... ... fabricator and installer of cleanrooms and cleanroom equipment announces ... the AireCell line of extrusions. The new extrusion allows greater ...
Cached Medicine News:Health News:Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida 2Health News:The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors 2Health News:Food Allergies Up 18% Among U.S. Children 2Health News:Endocare to Present at Oppenheimer 19th Annual Healthcare Conference 2Health News:DRE Medical Equipment Adds Affordable Refurbished Ultrasound Machines to Product Line 2Health News:DRE Medical Equipment Adds Affordable Refurbished Ultrasound Machines to Product Line 3Health News:Gerbig Engineering Introduces 7 " Deep Extrusions for Cleanroom Construction 2
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
Inquire...
Medicine Products: